On April 7, 2026, Lumonus, the creator of Lumonus AI, a system for radiation oncology clinical workflow and automated treatment planning, revealed a partnership with Memorial Sloan Kettering Cancer Center (MSK), a renowned institution in the field. The collaboration signifies a significant advancement in cancer care, bringing together Lumonus's innovative technology and MSK's expertise to enhance treatment processes. This partnership is expected to have a far-reaching impact, benefiting a large number of patients and healthcare professionals worldwide.